Showing results (221-230 of 317) with videos related to
Sort By:
Pageof 32
Journal of Clinical Medicine|October 14, 2023
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.Molecular Nutrition & Food Research|September 25, 2022
Long Term Weight Cycling Affects Fecal Microbiota of MiceChristèle Humblot, Yohannes Seyoum, Williams Turpin, et al.Scandinavian Journal of Gastroenterology|April 1, 2017
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)Carl Eriksson, Jan Marsal, Daniel Bergemalm, et al.Plos One|December 5, 2012
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's diseaseAlison R Erickson, Brandi L Cantarel, Regina Lamendella, et al.The American Journal of Gastroenterology|December 1, 2007
Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and predictionPeggy Vandewalle-El Khoury, Jean-Frederic Colombel, Sofie Joossens, et al.BMJ Open|May 16, 2024
Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT)Anja Fejrskov, Johannes David Füchtbauer, Lóa G Davíðsdóttir, et al.Gastroenterology|May 29, 2026
β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk CohortMingyue Xue, Cathy McShane, Jeongseok Kim, et al.Journal of Crohn'S & Colitis|March 9, 2012
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD populationWesley Leung, Gurtej Malhi, Barbara M Willey, et al.Journal of Crohn'S & Colitis|January 25, 2023
Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel DiseaseArchana Shubhakar, Bas C Jansen, Alex T Adams, et al.Inflammatory Bowel Diseases|October 26, 2018
Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk LociKimi Drobin, Ghazaleh Assadi, Mun-Gwan Hong, et al.Pageof 32